<VariationArchive RecordType="classified" VariationID="2582454" VariationName="NM_025099.6(CTC1):c.371_372dup (p.Glu125fs)" VariationType="Duplication" Accession="VCV002582454" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-07" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2750024" VariationID="2582454">
      <GeneList>
        <Gene Symbol="CTC1" FullName="CST telomere replication complex component 1" GeneID="80169" HGNC_ID="HGNC:26169" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8224815" stop="8248056" display_start="8224815" display_stop="8248056" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8128138" stop="8151412" display_start="8128138" display_stop="8151412" Strand="-" />
          </Location>
          <OMIM>613129</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025099.6(CTC1):c.371_372dup (p.Glu125fs)</Name>
      <CanonicalSPDI>NC_000017.11:8238454:CA:CACA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8238454" stop="8238455" display_start="8238454" display_stop="8238455" variantLength="2" positionVCF="8238454" referenceAlleleVCF="C" alternateAlleleVCF="CCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8141772" stop="8141773" display_start="8141772" display_stop="8141773" variantLength="2" positionVCF="8141772" referenceAlleleVCF="C" alternateAlleleVCF="CCA" />
      </Location>
      <ProteinChange>E125fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1124" sequenceAccession="LRG_1124">
            <Expression>LRG_1124:g.14640_14641dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1124t1" sequenceAccession="LRG_1124t1">
            <Expression>LRG_1124t1:c.371_372dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1124p1" sequenceAccession="LRG_1124p1" change="p.Glu125fs">
            <Expression>LRG_1124p1:p.Glu125fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.8141773_8141774dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.8141773_8141774dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.8238455_8238456dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.8238455_8238456dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032148.2" sequenceAccession="NG_032148" sequenceVersion="2" change="g.14640_14641dup">
            <Expression>NG_032148.2:g.14640_14641dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001411067.1" sequenceAccession="NM_001411067" sequenceVersion="1" change="c.371_372dup">
            <Expression>NM_001411067.1:c.371_372dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397996.1" sequenceAccession="NP_001397996" sequenceVersion="1" change="p.Glu125fs">
            <Expression>NP_001397996.1:p.Glu125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025099.6" sequenceAccession="NM_025099" sequenceVersion="6" change="c.371_372dup" MANESelect="true">
            <Expression>NM_025099.6:c.371_372dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079375.3" sequenceAccession="NP_079375" sequenceVersion="3" change="p.Glu125fs">
            <Expression>NP_079375.3:p.Glu125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046431.2" sequenceAccession="NR_046431" sequenceVersion="2" change="n.391_392dup">
            <Expression>NR_046431.2:n.391_392dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025099.6(CTC1):c.371_372dup (p.Glu125fs) AND Cerebroretinal microangiopathy with calcifications and cysts 1" Accession="RCV003333441" Version="1">
        <ClassifiedConditionList TraitSetID="7901">
          <ClassifiedCondition DB="MedGen" ID="C4552029">Cerebroretinal microangiopathy with calcifications and cysts 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7901" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1351" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebroretinal microangiopathy with calcifications and cysts 1</ElementValue>
                <XRef ID="Cerebroretinal+microangiopathy+with+calcifications+and+cysts/7948" DB="Genetic Alliance" />
                <XRef ID="MONDO:0024564" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CRMCC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CRMCC1</ElementValue>
                <XRef Type="MIM" ID="612199" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="313838" DB="Orphanet" />
              <XRef ID="C4552029" DB="MedGen" />
              <XRef ID="MONDO:0024564" DB="MONDO" />
              <XRef Type="MIM" ID="612199" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7562487" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="42478|OMIM:612199" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004040993" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.6:c.371_372dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612199" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858665</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7562487" TraitType="Disease" MappingType="XRef" MappingValue="612199" MappingRef="OMIM">
        <MedGen CUI="C4552029" Name="Cerebroretinal microangiopathy with calcifications and cysts 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

